Antimicrobials have been widely used in veterinary medicine for disease treatment, disease prevention, and growth promotion. Although, the mechanisms about in-feed additives use are still not completely understood, it is accepted that its use improves feed efficiency by reducing the microbial load in the intestinal tract, thereby reducing the pressure on the immune system and increasing energy availability for the animal. However, disruption to commensal bacterial communities by antibiotics in some cases can increase the gut colonization by pathogenic bacteria. In this sense, the aim of this study was to evaluate the Escherichia coli antibiotic resistance and the gut microbiota profile from pigs raised in Brazilian farms with different in-feed antimicrobials protocols. Pigs from four farms with distinct antibiotic usage, including one farm that used no antibiotics, were followed from weaning to finishing, and the frequency of antimicrobial resistance and gut bacterial profile by 16S rRNA gene sequencing were evaluated. The gut microbial community structure was the same among all groups of pigs despite different antibiotic use on the farms; however, the antimicrobial resistance profiles of E. coli isolates were different between groups. One farm administered seven antibiotics at different times, and E. coli isolates from these pigs showed higher frequency of resistance and multidrug resistance as compared with samples from the farm that did not administer in-feed antimicrobials. The phenotypes included resistance to drugs considered critically important antimicrobial agents in veterinary medicine (ampicillin, ciprofloxacin, florfenicol, sulfonamide and tetracycline) as well as one highly important antibiotic in human medicine (colistin). Resistant E. coli strains were screened for the presence of the mcr-1 gene by PCR. The colistin-resistant strains were positive for the presence of the mcr-1 gene. These results suggest that although different antibiotic uses on-farm might not impact microbial community structure, it does impact bacterial functions, namely antibiotic resistance. Our results show that prudent use of antimicrobials is important for decreasing selective pressure for antibiotic resistance gene evolution.
Introduction
Antimicrobials have been widely used in veterinary medicine for therapeutic and non-therapeutic purposes. The non-therapeutic use can affect the gut microbiome balance, and may increase the gut colonization by pathogenic and antimicrobial resistant th International Symposium on the Epidemiology and Control of Biological, Chemical and Physical Hazards in Pigs and Pork Foz do Iguaçu -Brazil | August 21-24, 2017 bacteria. In this sense, meat products can act as vehicles of resistant strains (Chantziaras et al., 2014; Boeckel et al., 2015) .
In order to study the effect of continuous in-feed antimicrobial administration on bacterial resistance, many studies used Escherichia coli as a biological indicator. It's known that the resistance profile of E. coli strains may vary according to in-feed antimicrobial administration protocol (Chantziaras et al., 2014; EFSA, 2015) . This administration can also have an effect on the gut microbiota (Looft at al., 2012; Kim et al., 2012; Fleury et al., 2016) . However, it is not clear if the gut microbiota structure in pigs from in-feed antimicrobial free farms is different compared to pigs grown in farms, where antimicrobials are used massively. In order to contribute to this knowledge, the aim of this study was to describe the gut microbiota and E. coli phenotypic resistance profile in pigs grown in farms adopting different in-feed antimicrobial administration protocols.
Material and methods
Gut microbiota and E. coli antimicrobial resistance profile were investigated in four groups of swine submitted to different in-feed antimicrobial administration protocols from 32 to 140 days old. The study was conducted at Embrapa Swine and Poultry (Brazil) and the farms were located at the same region.
Swine groups
 G1: Piglets from a very small farrow to finishing operation (462 finished pigs per year), without in-feed antimicrobials administration since 2008.  G2: A subgroup of G1, submitted to three ten-day pulses of in-feed antimicrobial administration: colistin (120 ppm) at the nursery; doxycycline (200 ppm) and tiamulin (120 ppm) at the growing phase; and florfenicol (120 ppm) at the finishing phase.  G3: Piglets from a small farrow to finishing operation (1,100 finished pigs per year). In-feed antimicrobials were used continuously: colistin (133 ppm) from farrow to nursery; halquinol (4000 ppm) at the growing phase; and lincomycin (733 ppm) at the finishing phase.  G4: Piglets from a medium farrow to finishing operation (28,800 finished pigs per year). In-feed antimicrobials were used continuously: florfenicol (60 ppm) and norfloxacin (200 ppm) in nursery (first week), colistin (200 ppm) and neomycin (200 ppm) until end of nursery stage; halquinol (120 ppm) and tiamulin (150 ppm) at growing stage; tylosin (80 ppm) at finishing stage.
Sampling
Six piglets from three different litters were identified and sampled at four time points: nursery (days 32 and 47 of age); growing (day 63 of age); and finishing (ten days before slaughter) stages. Two producing cycles in each farm were sampled, totaling 183 feces samples.
Microbiota analysis
For this analysis, feces samples from four animals in one sampling cycle were used (n = 64). The fecal DNA was extracted by Power Fecal kit (MoBio Laboratories). The V1-V3 region of bacterial 16S rRNA gene was amplified and sequenced in the MiSeq plataform (Illumina). Sequence data analysis was performed with mothur software package version 1.34.4. Statistical analysis for taxonomic differences was conducted using the STAMP software. T-test with Storey FDR multiple comparison correction was used to detect significant differences in taxonomic distribution between samples, with the unclassified reads retained in the analyses.
Isolation and antimicrobial susceptibility test of Escherichia coli
Escherichia coli was isolated on Eosin Methilene Blue Agar (EMB) and one isolate per animal was tested for susceptibility against ten different antimicrobial agents: ampicillin (10 µg); cefotaxime (30 μg); ceftazidime (30 μg); ciprofloxacin (5 μg); chloramphenicol (30 µg); florfenicol (30 µg); gentamicin (10 µg); nalidixic acid (30 µg); sulfonamide (300 µg); and tetracycline (30 µg), according to CLSI (VET01-S2 and M100S documents). Antimicrobial resistance frequencies in the groups were compared by the chi-square test (χ2) with 95% of confidence. In addition, Marascuilo procedure was performed to test the differences between categories. For colistin, the Minimal Inhibitory Concentration (MIC) was determined. All isolates were also screened for the presence of mcr-1 gene by PCR (Liu et al., 2016) .
Results and discussion
Microbiota analysis produced a total of 853,301 reads with an average of 488 bases (280 to 582). From them, 164,351 reads were used for assessing bacterial diversity. Among the OTUs 99.16% were identifiable, and the majority was assigned to the phyla Firmicutes (65.43%) and Bacterioidetes (27.98). These groups have been identified as part of the gut microbiota in pigs (Looft et al., 2012; Kim et al., 2015; Mach et al., 2015) . At the genus level, Prevotella and Ocillibacter followed by Bacteroides and Lachnospiracea were the most frequent groups. Prevotella, which belongs to the phylum Bacteroidetes, is the most frequent genus in pig gut microbiota (Looft et al., 2012; Mach et al., 2015) . This genus has been associated with feed fermentation and provision of energy to the host (Lamandella et al., 2011) . Oscillibacter, which belongs to the phylum Firmicutes, ranged from 17.64 to 19.92% of all classifiable genera identified in the four pig groups. Ocillibacter has been reported as a low frequent genus in the gut microbiota of adult pigs. On the contrary, this genus together with Bacteroides may predominate in piglets, due to their ability of utilization of oligosaccharides present in the milk (Park et al., 2014; Mach et al., 2015) . Overall, no significant difference on the gut microbiota profile was detected among the four pig groups or between growth stages.
As in other studies, Escherichia, which belongs to the phylum Proteobacteria, was amongst the least common genera of the gut microbiota. Despite this fact, E. coli has been adopted as an antimicrobial resistance indicator in animals (EFSA, 2015) . Evaluation of antimicrobial susceptibility test was carried out in 183 E. coli isolates (Table 1) . Overall, 7.65% were susceptible to all antimicrobials tested and 78.14% were considered multidrug-resistant (MDR) (resistant to  3 antimicrobial classes). Among the pig groups, G4 presented the highest frequency of MDR strains (22.95%), followed by G3, G2 and G1 (21.3%, 19.7% and 14.2%, respectively). Significant differences between groups were observed in the resistance to ampicillin, ciprofloxacin, chloramphenicol, florfenicol, sulfonamide and tetracycline (P < 0.05). Regarding colistin, most E. coli strains displaying MICs 8 ug.mL -1 belonged to G3 and G4 (Table 2) . Among the resistant strains, mcr-1 gene was detected in 77.5% of them. This is a matter of concern, since this gene may be located in plasmids and be transferred among bacteria, decreasing the colistin efficacy in controlling swine diseases. Moreover, the hazard for humans has been pointed out, because this drug is considered the last option for human treatment (Liu et al., 2016) . 
Conclusion
These results suggest that although different antibiotic uses on-farm might not impact microbial community structure, it does impact bacterial functions, namely antibiotic resistance. Our results show that prudent use of antimicrobials is important for decreasing selective pressure for antibiotic resistance gene evolution.
